Posted on 11/04/08
New rules: life-saver or safety risk?
The pharmaceutical industry, health experts and patient groups across Canada are strongly divided over whether the federal government's proposed new system for approving and monitoring drugs will result in harm or benefit to Canadians.
The full text of this article has 616 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
